Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compos

Details Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compos Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compos

1983-04-04

1985-03-05

Brust, Joseph Paul

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546272, 548444, 514339, A61K 3140, C07D40112, C07D20982

Patent

active

045030677

ABSTRACT:
Carbazolyl-(4)-oxypropanolamine compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkanoyl or aroyl;

REFERENCES:
patent: 1834015 (1931-12-01), Ballauf et al.
patent: 2944058 (1960-07-01), Kallischnigg
patent: 3846445 (1974-11-01), Bondesson et al.
patent: 3932424 (1976-01-01), Albrecht et al.
patent: 3975398 (1976-08-01), Werner et al.
patent: 3976779 (1976-08-01), Leinert et al.
patent: 3998810 (1976-12-01), Wiedemann et al.
patent: 4076829 (1978-02-01), Kampe et al.
patent: 4086357 (1978-04-01), Large et al.
patent: 4115409 (1978-09-01), Large et al.
patent: 4152446 (1979-05-01), Kampe et al.
Ulrych et al., Circulation 37, 411-416 (1968).
Kaplan, N.M., Clinical Hypertension, 2nd ed. pp.125-128.
Waal, H.J. Clinical Pharmacology and Therapeutics vol. 7, 588-598 (1966).
J.A.M.A 237, 2303-2310 (1977).
Gilmore, E. et al., The New England Journal of Medicine 282, 521-527 (1970).
Zacest, R., et al. The New Journal of Medicine 286, 617-622 (1972).
Weiner, N., The Pharmacological Basis of Therapeutics (1980) Chap. 9, pp. 176, 188, 191, 194.
Conway et al., Medical Science and Molecular Medicine 48, 101s-103s (1975).

Affiliated with

Also associated with

Rating

Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compos does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compos will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1734207